- Marijuana and Terpenes: An OverviewPosted 973 days ago
- Is Marijuana Addictive?Posted 1056 days ago
- Does Marijuana Cause Lung Damage?Posted 1111 days ago
- What Makes Marijuana a ‘Psychoactive’ Substance?Posted 1115 days ago
- How Does Marijuana Affect Dopamine?Posted 1165 days ago
- Can You Overdose On Marijuana?Posted 1167 days ago
- What is CBD?Posted 1170 days ago
- What is THC?Posted 1172 days ago
- Does Marijuana Cause Brain Damage?Posted 1198 days ago
- Cannabis: A Powerful AntioxidantPosted 1198 days ago
CBD May Reverse Brain Deficits In Parkinson’s, Alzheimer’s
TruthOnPot.com – Scientists have identified a role of cannabidiol (CBD) in countering chemical imbalances in the brain, which they say could be useful in treating a number of disorders.
The chemical in question is iron. Despite being an essential nutrient, high levels of iron can damage brain cells and lead to impairments such as memory loss in Alzheimer’s. Abnormal iron levels have also been linked to the progression of Parkinson’s Disease.
Using CBD, researchers from Brazil were able to reverse markers of brain damage caused by high doses of iron in rats – restoring them to normal levels. The results were able to confirm observations from an earlier study, where a single dose of CBD was “able to recover memory in iron-treated rats.”
Writing in the July issue of Molecular Neurobiology, they concluded that CBD has significant potential in restoring brain function and protecting the brain from further damage.
“Our findings support the potential of cannabidiol in reversing cognitive decline and its clinical use in treating neurodegenerative disorders such as Parkinson’s Disease and Alzheimer’s Disease.”
Iron has been shown to cause brain degeneration by promoting oxidative stress. On the other hand, CBD – a non-psychoactive chemical found in marijuana – is known to have powerful antioxidant properties, making it “a promising candidate” for treating these disorders, wrote the authors.
The study was conducted at Pontifical Catholic University and funded by the National Institute for Translational Medicine (INCT-TM).